IBDEI0TS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14694,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,14694,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,14694,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,14695,0)
 ;;=729.1^^89^897^35
 ;;^UTILITY(U,$J,358.3,14695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14695,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,14695,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,14695,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,14696,0)
 ;;=438.20^^89^897^11
 ;;^UTILITY(U,$J,358.3,14696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14696,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,14696,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,14696,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,14697,0)
 ;;=438.12^^89^897^8
 ;;^UTILITY(U,$J,358.3,14697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14697,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,14697,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,14697,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,14698,0)
 ;;=356.8^^89^897^90
 ;;^UTILITY(U,$J,358.3,14698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14698,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,14698,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,14698,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,14699,0)
 ;;=337.20^^89^897^100
 ;;^UTILITY(U,$J,358.3,14699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14699,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,14699,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,14699,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,14700,0)
 ;;=294.8^^89^897^33
 ;;^UTILITY(U,$J,358.3,14700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14700,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,14700,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,14700,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,14701,0)
 ;;=438.6^^89^897^7
 ;;^UTILITY(U,$J,358.3,14701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14701,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,14701,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,14701,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,14702,0)
 ;;=438.7^^89^897^26
 ;;^UTILITY(U,$J,358.3,14702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14702,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,14702,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,14702,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,14703,0)
 ;;=438.84^^89^897^5
 ;;^UTILITY(U,$J,358.3,14703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14703,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,14703,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,14703,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,14704,0)
 ;;=434.91^^89^897^27
 ;;^UTILITY(U,$J,358.3,14704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14704,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,14704,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,14704,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,14705,0)
 ;;=333.94^^89^897^101
 ;;^UTILITY(U,$J,358.3,14705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14705,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,14705,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,14705,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,14706,0)
 ;;=345.90^^89^897^104
 ;;^UTILITY(U,$J,358.3,14706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14706,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,14706,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,14706,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,14707,0)
 ;;=907.0^^89^897^73
